Inventor · disambiguated record
Guangcheng Jiang
Also filed as: JIANG GUANGCHENG
28 granted patents·1 pending application·899 citations·filing 1994–2018
97Inventor score
Files withCARA THERAPEUTICS INC12FERRING BV7SCHTEINGART CLAUDIO D6SALK INST FOR BIOLOGICAL STUDI2ALAGARSAMY SUDARKODI1
Top patents by PatentIndex Score
29 records- 0198US7402564B1Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2007·Granted Jul 22, 2008·88 cites·10 claims
- 0297US8217007B1Synthetic peptide amidesSCHTEINGART CLAUDIO D·Filed 2010·Granted Jul 10, 2012·64 cites·20 claims
- 0397US7842662B2Synthetic peptide amide dimersCARA THERAPEUTICS INC·Filed 2007·Granted Nov 30, 2010·56 cites·23 claims
- 0497US7727963B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2008·Granted Jun 1, 2010·59 cites·23 claims
- 0596US8536131B2Synthetic peptide amides and dimers thereofSCHTEINGART CLAUDIO D·Filed 2010·Granted Sep 17, 2013·54 cites·23 claims
- 0696US8486894B2Synthetic peptide amides and dimeric forms thereofSCHTEINGART CLAUDIO D·Filed 2010·Granted Jul 16, 2013·55 cites·14 claims
- 0796US8236766B2Uses of synthetic peptide amidesSCHTEINGART CLAUDIO D·Filed 2009·Granted Aug 7, 2012·58 cites·13 claims
- 0896US7713937B2Synthetic peptide amides and dimeric forms thereofCARA THERAPEUTICS INC·Filed 2008·Granted May 11, 2010·62 cites·60 claims
- 0993US8906859B2Uses of kappa opioid synthetic peptide amidesSCHTEINGART CLAUDIO D·Filed 2010·Granted Dec 9, 2014·12 cites·23 claims
- 1092US9321810B2Uses of kappa opioid synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2014·Granted Apr 26, 2016·8 cites·20 claims
- 1191US9359399B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2014·Granted Jun 7, 2016·10 cites·20 claims
- 1291US5506207AGNRH antagonists XIIISALK INST FOR BIOLOGICAL STUDI·Filed 1994·Granted Apr 9, 1996·90 cites·15 claims
- 1390US10138270B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2016·Granted Nov 27, 2018·6 cites·15 claims
- 1490US10017536B2Synthetic peptide amides and dimers thereofCARA THERAPEUTICS INC·Filed 2016·Granted Jul 10, 2018·7 cites·16 claims
- 1590US8951970B2Synthetic peptide amides for painSCHTEINGART CLAUDIO D·Filed 2012·Granted Feb 10, 2015·11 cites·24 claims
- 1690US7816489B2Methods for making intermediates and oxytocin analoguesFERRING BV·Filed 2007·Granted Oct 19, 2010·10 cites·9 claims
- 1789US9334305B2Synthetic peptide amides and dimers thereofCARA THERAPEUTICS INC·Filed 2013·Granted May 10, 2016·10 cites·38 claims
- 1886US7091314B2Intermediates and methods for making heptapeptide oxytocin analoguesFERRING BV·Filed 2004·Granted Aug 15, 2006·11 cites·15 claims
- 1986US6214798B1GnRH antagonists being modified in positions 5 and 6FERRING BV·Filed 1998·Granted Apr 10, 2001·62 cites·20 claims
- 2086US5925730AGnRH antagonistsFERRING BV·Filed 1997·Granted Jul 20, 1999·60 cites·21 claims
- 2184US10793596B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·2 cites·18 claims
- 2284US7304181B2Methods for making intermediates and oxytocin analoguesFERRING BV·Filed 2006·Granted Dec 4, 2007·4 cites·20 claims
- 2382US5821230AGnRH antagonist decapeptidesFERRING BV·Filed 1997·Granted Oct 13, 1998·57 cites·20 claims
- 2479US8580918B2Peptidic GLP-2 agonistsALAGARSAMY SUDARKODI·Filed 2010·Granted Nov 12, 2013·9 cites·36 claims
- 2570US5807983AGNRH antagonist betidesSALK INST FOR BIOLOGICAL STUDI·Filed 1996·Granted Sep 15, 1998·34 cites·20 claims
- 2668US10913769B2Synthetic peptide amides and dimers thereofCARA THERAPEUTICS INC·Filed 2018·Granted Feb 9, 2021·0 cites·16 claims
- 2759US2016310558A1Uses of kappa opioid synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2835US9969775B2CGRP antagonist peptidesFERRING BV·Filed 2016·Granted May 15, 2018·0 cites·17 claims
- 2920US9260480B2Process for the manufacture of Degarelix and its intermediatesKALITA DIPAK·Filed 2011·Granted Feb 16, 2016·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Guangcheng Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →